Genus plc (GENSY)
OTCMKTS · Delayed Price · Currency is USD
24.34
+1.34 (5.83%)
At close: Apr 11, 2025
Genus Employees
Genus had 3,500 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
3,500
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$263,363
Profits / Employee
$7,555
Market Cap
2.25B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3,500 | 0 | - |
Jun 30, 2023 | 3,500 | 0 | - |
Jun 30, 2022 | 3,500 | 100 | 2.94% |
Jun 30, 2021 | 3,400 | 300 | 9.68% |
Jun 30, 2020 | 3,100 | 100 | 3.33% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
CytoDyn | 13 |
Silence Therapeutics | 116 |